osteoporosis
bone cavity formation d/t l/o bone mass –> inc fragility to bones –> fracture
etiology
multifactorial (complex):
risk factors
1) low peak bone mass (BPM)
2) post menopausal women (inc bone loss) –> estrogen prod dec
why does dec estrogen production inc risk for osteoporosis
Estrogen has protective effect on bone, involved in maintaining balance b/w osteoblast & osteoclast activity –> produces mediators to inhibit osteoclast activity & regulate breakdown
patho
mnfts
why does reduced height & change in stature mnft
Vertebrae loses bone mass
why does dyspnea mnft
External pressure applied on ribcage d/t hunched stature –> inhibit lung expansion
cmplx of loose & degraded teeth (mnft)
Cannot chew hard foods –> impacts diet –> dietary deficiencies
Dx
bone density scans
Tx
pharmacology:
- antiresorptive agents
- anabolic agents
why is weight-bearing activity a Tx
it stimulates osteoclast activity (same action as estrogen)
ex. brisk walking, jogging, etc.
antiresorptive agents
inhibits osteoclast activity (same action as estrogen)
anabolic agents
enhances osteoclast activity (more bone deposition to outweigh breakdown)
cmplx
fractures